Radiation Oncology Department, centre hospitalier universitaire de Brest, Brest, France; Inserm, LaTim UMR 1101, université de Bretagne occidentale, Brest, France.
Radiation Oncology Department, centre Henri-Becquerel, Rouen, France; QuantIf-Litis EA4108, université de Rouen, Rouen, France.
Cancer Radiother. 2023 Sep;27(6-7):659-665. doi: 10.1016/j.canrad.2023.06.021. Epub 2023 Jul 27.
Ultracentral (UC) lung lesions are generally defined by the presence of the tumour or the Planning Target Volume (PTV) abutting proximal bronchial tree (PBT) or the esophagus. Initial reports rose awareness regarding the potential toxicity of stereotactic body radiotherapy (SBRT) when delivered to UC lesions. Major concerns include necrosis, stenosis, and bleeding of the PBT. Technological improvements now enable the delivery of more accurate treatments, possibly redefining the historical "no-fly zone". In this review, studies focusing on the treatment of UC lesions with SBRT are presented. The narrow therapeutic window requires a multidisciplinary approach.
超中央(UC)肺部病变一般通过肿瘤或计划靶区(PTV)与近端支气管树(PBT)或食管相邻来定义。最初的报告引起了人们对立体定向体放射治疗(SBRT)应用于 UC 病变时潜在毒性的关注。主要关注的问题包括 PBT 的坏死、狭窄和出血。技术的进步现在使更精确的治疗成为可能,这可能重新定义了历史上的“禁飞区”。在这篇综述中,介绍了 SBRT 治疗 UC 病变的研究。由于治疗的窗口较窄,需要采用多学科的方法。